NCT02500186: The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor |
|
|
| Completed | N/A | 24 | NA | Luseogliflozin, Lusefi tab. 2.5mg, Meal containing different carbohydrate ratio and GI value | Kansai Electric Power Hospital, Medical Corporation Heishinkai OCROM Clinic | Diabetes Melltius, Type 2 | 12/15 | 12/15 | | |
NCT02284269: Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus |
|
|
| Unknown status | N/A | 18000 | NA | SGLT2 Inhibitors | Pharmaceuticals and Medical Devices Agency, Japan | Diabetes Mellitus, Type 2 | 05/20 | | | |
